'Consumers Taking Action'
Defective Drugs:
Dead Jaw Linked to Fosamax
Fosamax Details
- This Alert Affects: Patients who have taken osteonecrosis of the jaw while taking Fosomax.
- Damages: Fosamax has been linked to osteonecrosis of the jaw (dead jaw) and spontaneous femur fractures.
- Company(ies): Merck
- Additional Details: Fosamax treats osteoporosis in postmenopausal women.
- Date: The Fosamax label was updated to include the risk of dead jaw in July 2005.
- Fosamax: Click for a Free Attorney Review
- Read visitor comments about Fosamax
Fosamax Lawsuits
Manufactured by Merck, Fosamax is used to treat postmenopausal osteoporosis. Fosamax is a biphosphonate, which treats and prevents bone loss. However, research has shown that drugs containing biphosphonate can cause osteonecrosis, or dead jaw.
Dead jaw occurs when bone tissue in the jaw cannot heal after minor dental work, including tooth extraction, crown placements and root canals. Dead jaw leaves the bone exposed, and may lead to infections, rotting and fractures. Some patients suffering from osteonecrosis may require surgery or lengthy antibiotic treatments. Common symptoms of dead jaw include gum infections, gum swelling, exposed bone, loosening of the teeth or numbness in the jaw.
| First Name |
Last Name |
||
| Email |
Zip Code |
||
| Phone Number |
Enter the 4 digit number below | ||
 |
|||
| Case Details |
|||
View Comments
Tell Us What You Think
No comments have been added in the past seven days. Feel free to add a comment!
If you would like to add a comment to this article about Fosamax, simply fill out the form below. All comments will be moderated before they are posted. Please do not use any HTML.